2026 NPPES data Clinical & Laboratory Immunology (Allergy & Immunology) Physician NPI 1568446581 MD
Verify on CMS →

Thomas Beller, MD

Clinical & Laboratory Immunology (Allergy & Immunology) Physician in Hardeeville, South Carolina.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 97 in Clinical & Laboratory Immunology (Allergy & Immunology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 316 beneficiaries · Clinical & Laboratory Immunology (Allergy & Immunology) Physician avg: 773
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
92.5/100
▲ 9 pts above national avg 83.5 · Exceptional
Industry payments
$448.14
25 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Thomas Beller, MD reported a CMS MIPS final score of 92.5/100 - above the 83.5 national average - and filed 1,236 Medicare Part D claims in 2024.

92.5/100
MIPS score · +9 vs avg
1K
Part D claims, 2024
78%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Thomas Beller, MD

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1568446581), first enumerated 12/02/2005.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,236 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 92.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Industry payment transparency

    $448.14 in reported industry payments (25 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1568446581 · Clinical & Laboratory Immunology (Allergy & Immunology) Physician

NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1568446581
  • ENUM-LEGACY 2005
  • TAX-TRACE 97
  • MIPS-ABOVE 92.5/100
  • RX-MID 1,236
  • BOOK-THIN 3 in South Carolina
  • PHOTO-FINISH Selina Gierer · ±0.6

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Thomas Beller, MD's MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

93 ≥ 66th percentile 66% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). Below this entry. 90+: 189,403 measured providers (42%). This entry sits in this band. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic, not verified)

Thomas Beller, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Thomas Beller, MD?

High performer (top quartile)

NPI registry status

Active

Issued 12/02/2005

NPI 1568446581

Primary specialty

Clinical & Laboratory Immunology (Allergy & Immunology) Physician

Rare

97 US NPIs in this specialty

Medicare Part D claims

1,236 60% vs specialty avg

2024 prescription claims

Specialty avg: 773

MIPS final score

92.5/100 9 pts vs avg

Exceptional band

vs 83.5 national avg

Specialty distribution in South Carolina

How Clinical & Laboratory Immunology (Allergy & Immunology) Physician compares to other specialties among South Carolina providers

South Carolina providers
Pharmacist6.1%Mental Health Counselor5%Family Nurse Practitioner4.5%Physical Therapist4.5%Behavior Technician4.2%Speech-Language Pathologist3.6%Clinical & Laboratory Immuno…0%
Largest specialties in South Carolina (% of in-state providers)

Medicare quality performance, MIPS

Thomas Beller, MD's 2023 MIPS final score plotted against the Clinical & Laboratory Immunology (Allergy & Immunology) Physician national average

High performer (top quartile)
MIPS Final Score
92.5/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%92.5%
MIPS final score (Clinical & Laboratory Immunology (Allergy & Immunology) Physician) - 92.5/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

300 NEW RIVER PARKWAY
Hardeeville, SC 29927

Provider Details

NPI 1568446581
Specialty Clinical & Laboratory Immunology (Allergy & Immunology) Physician
Credentials MD
Gender Male
NPI Issued 12/02/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

92.4748
Final Score
Measured-score avg: 83.5
100
Quality
74.916
Cost

Reporting: Individual

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Thomas Beller, MD. Source: openpaymentsdata.cms.gov.

Total received

$448

Largest payer

CSL Behring

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Thomas Beller, MD - brand share 22.0%
Clinical & Laboratory Immunology (Allergy & Immunology) Physician average

22% brand-name claims vs 78% generic, on 1,236 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,236
Total Claims
$1.2M
Total Drug Cost
316
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,172.667
Total Day Supply
61,930
Brand vs Generic
22% brand / 78% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$27K
Antibiotic Claims
41

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
0.90
Gender Split
69% female / 31% male
Age Distribution
<65: 15, 65-74: 141, 75-84: 138, 85+: 22

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Thomas Beller, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Gabapentin
359
Ipratropium Bromide
86
Montelukast Sodium
83
Albuterol Sulfate Hfa
Albuterol Sulfate
77
Epinephrine
65
Prednisone
65
Fluticasone Propionate
54
Omeprazole
50
Symbicort
Budesonide/Formoterol Fumarate
41
Breo Ellipta
Fluticasone/Vilanterol
30

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical & Laboratory Immunology (Allergy & Immunology) Physician Overview

How Thomas Beller, MD fits within the Clinical & Laboratory Immunology (Allergy & Immunology) Physician landscape nationally.

97
Clinical & Laboratory Immunology (Allergy & Immunology) Physician Providers in US
29
States with Clinical & Laboratory Immunology (Allergy & Immunology) Physician
773
Avg Claims per Provider

Thomas Beller, MD's 1,236 claims are above the specialty average of 773.

Nationwide Clinical & Laboratory Immunology (Allergy & Immunology) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Beller, both outside South Carolina so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (92.5 here).

Same NPPES enumeration year (2005)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Clinical & Laboratory Immunology (Allergy & Immunology) Physician Providers in South Carolina

Other clinicians with the same primary specialty enrolled in South Carolina, drawn from the same CMS NPPES roster as Beller.

One of 3 Clinical & Laboratory Immunology (Allergy & Immunology) Physician providers enrolled in South Carolina, 2 are shown here.

Compare Clinical & Laboratory Immunology (Allergy & Immunology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Thomas Beller, MD's specialty?
Thomas Beller, MD specializes in Clinical & Laboratory Immunology (Allergy & Immunology) Physician and practices in Hardeeville, South Carolina. Credentials: MD.
How much does Thomas Beller, MD prescribe under Medicare Part D?
In 2024, Thomas Beller, MD wrote 1,236 Medicare Part D claims totaling $1.2M in drug costs for 316 beneficiaries.
What is Thomas Beller, MD's Medicare quality score?
Thomas Beller, MD has a CMS MIPS Final Score of 92.5/100 (Quality: 100, Cost: 74.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Thomas Beller, MD located?
Thomas Beller, MD is located at 300 NEW RIVER PARKWAY, Hardeeville, SC, 29927. Phone: (843) 208-6442.
What is Thomas Beller, MD's NPI number?
Thomas Beller, MD's National Provider Identifier (NPI) is 1568446581, issued on 12/02/2005.
Does Thomas Beller, MD prescribe more brand-name or generic drugs?
Thomas Beller, MD's prescribing is 22% brand-name and 78% generic drugs by claim count, with $1.2M in brand drug costs.
How many Clinical & Laboratory Immunology (Allergy & Immunology) Physician providers are there in the US?
There are 97 Clinical & Laboratory Immunology (Allergy & Immunology) Physician providers across 29 states in the US. The average Clinical & Laboratory Immunology (Allergy & Immunology) Physician provider writes 773 Medicare Part D claims per year.
What drugs does Thomas Beller, MD prescribe most often?
Based on 2024 Medicare Part D data, Thomas Beller, MD's most frequently prescribed drugs include Gabapentin, Ipratropium Bromide, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Thomas Beller, MD accept Medicare?
Thomas Beller, MD appears in CMS Medicare data with 1,236 Part D claims and 316 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Thomas Beller, MD's credentials?
Thomas Beller, MD's NPI is 1568446581 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.